Clinical Trials Update: June 8, 2006
Migraine and Cluster Headaches Cutaneous Lupus Erythematosus Rheumatoid Arthritis
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
Migraine and Cluster Headaches
This medical research study will evaluate how well an approved medicine works for migraine headaches. To qualify, you must be 18 to 65 with a history of migraines. Study-related medication or placebo, as well as study-related medical care will be provided at no cost.
The research site is in Dallas, Texas.
Cutaneous Lupus Erythematosus
People between 18 and 60 with refractory cutaneous lupus erythematosus are needed to participate in a research study of a monoclonal antibody. Volunteers who are otherwise in good health and have been on a stable dose of any existing medications for four weeks may qualify. Two overnight stays are required, and multiple blood draws will be performed throughout the study.
The research site is in Lenexa, KS.
This study will evaluate the safety and effectiveness of fontolizumab to treat active rheumatoid arthritis. Candidates must be at least 18 diagnosed with rheumatoid arthritis functional class I, II, or III for at least six months. Participants also must have at least six swollen joints and six tender, painful joints, and must have been on a stable rheumatoid arthritis treatment for at least 30 days.
The research sites are located throughout the United States.
Copyright 2006 Thomson CenterWatch. All rights reserved.